Review
Accepted on 10 Feb 2025
Central nervous system and immune cells interactions in cancer: unveiling new therapeutic avenues
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1528363
Type at least 3 characters
7,152 articles
Articles
Review
Accepted on 10 Feb 2025
Tandem CAR-T cell therapy: recent advances and current challenges
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1546172
- 137 views
Original Research
Accepted on 10 Feb 2025
Integrated multiomics analysis and machine learning refine neutrophil extracellular trap-related molecular subtypes and prognostic models for acute myeloid leukemia
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1558496
Mini Review
Accepted on 10 Feb 2025
The Role of Tumor-Associated Macrophages in Lung Cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1556209
Original Research
Accepted on 10 Feb 2025
Exploring Radiation Resistance-Related Genes in Pancreatic Cancer and Their Impact on Patient Prognosis and Treatment
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1524798
Original Research
Accepted on 10 Feb 2025
Exposing the Cellular Situation: Findings from Single-Cell RNA Sequencing in Breast Cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1539074
Review
Accepted on 10 Feb 2025
Advances in the Role of NK Cells in MDS Immune Dysfunction and Antitumor Research
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1511616
Original Research
Accepted on 10 Feb 2025
Big data analysis and machine learning of the role of cuproptosis-related long non-coding RNAs (CuLncs) in the prognosis and immune landscape of ovarian cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1555782
- 134 views
Review
Accepted on 10 Feb 2025
The multi-faceted immune modulatory role of S100A4 in cancer and chronic inflammatory disease
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1525567
Original Research
Accepted on 10 Feb 2025
Identification of Immune Subtypes Associated with CD8+ T Cell-Related Genes Providing New Treatment Strategies of Esophageal Carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1512230
Case Report
Accepted on 10 Feb 2025
Case report: The immune architecture of immunotherapy-induced cutaneous sarcoidosis resembles peritumoral inflammation
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1432927
- 120 views
Original Research
Published on 10 Feb 2025
Assessing hemorrhagic risks in combination therapy: implications of angiogenesis inhibitors and immune checkpoint inhibitors
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1527570
- 319 views
Original Research
Published on 10 Feb 2025
Efficacy of natural killer T and gammadelta T cells in mesothelin-targeted immunotherapy of pancreatic cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1524899
- 367 views
Systematic Review
Published on 10 Feb 2025
Bibliometric analysis of targeted immunotherapy for osteosarcoma-current knowledge, hotspots and future perspectives
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1485053
- 305 views
Systematic Review
Published on 10 Feb 2025
Bibliometric insight into neoadjuvant immunotherapy in non-small cell lung cancer: trends, collaborations, and future avenues
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1533651
- 262 views
Original Research
Published on 10 Feb 2025
Development and functional validation of a disulfidoptosis-related gene prognostic model for lung adenocarcinoma based on bioinformatics and experimental validation
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1540578
- 313 views